Company profile for LENZ Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products. LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 1...
LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products. LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
San Diego, CA
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/01/3196996/0/en/LENZ-Therapeutics-Announces-MFDS-Submission-of-New-Drug-Application-for-LNZ100-VIZZ-in-South-Korea-for-the-Treatment-of-Presbyopia.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/25/3194718/0/en/LENZ-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
25 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181420/0/en/LENZ-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Highlights.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/10/29/3176378/0/en/LENZ-Therapeutics-to-Report-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Highlights-on-November-5-2025.html

GLOBENEWSWIRE
29 Oct 2025

https://www.prnewswire.com/news-releases/lenz-therapeutics-announces-commercial-product-availability-of-vizz-in-the-united-states-302570157.html

PR NEWSWIRE
30 Sep 2025

https://www.globenewswire.com/news-release/2025/08/25/3138414/0/en/LENZ-Therapeutics-to-Present-at-Upcoming-Investor-and-Medical-Conferences.html

GLOBENEWSWIRE
25 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty